Key Drivers
- Strong Margins
- Healthy Cash Flow
- Intangible Asset Risk
AIAI Summary
PBH has shifted from a steady branded-staples story to a “prove-it” execution investment, where the stock can re-rate only if management quickly restores supply reliability, protects cash generation, and contains litigation/disclosure risk; until then, the downside is driven more by operational and credibility risk than by demand weakness.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Margins
- •Healthy Cash Flow
- •Intangible Asset Risk
PBH looks financially solid with strong margins, healthy cash generation, and manageable leverage, but its valuation is only moderate and the heavy intangible-asset load plus low asset turnover keep the risk profile from looking fully clean.
Price Behavior
Key Price Behavior Insights:
- •Rising lows
- •$47 support
- •$49.5 cap
PBH is constructive over the last month with rising lows and support near $47.00, but a sustained move above $49.50 is needed to confirm the rally.
Choppy action included a sharp drop from $49.41 to $47.27 before rebounding
Sentiment & News
Key News Insights:
- •Legal probes
- •Supply chain issues
- •Expansion financing
PBH faces mounting investor and legal scrutiny over alleged disclosure issues and weak Q4 execution, even as it expands with the Breathe Right acquisition and a new debt offering. #investor-scrutiny
The news likely keeps sentiment pressured in the near term, with legal overhang outweighing the positives from acquisition growth and financing activity
Similar Companies in Healthcare
Other companies in the same sector with AI ratings